Table 4 Crude odds ratios (OR) and adjusted OR (AOR) for confounders in various comparisons of patients who presented for operation for POP–Q II–III and genuine SUI between January 2006 and December 2012

Age

0.05

1.04 (1.00–1.08)

1.02 (0.97–1.08)

< 0.001

1.07 (1.04–1.11)

1.05 (1.01–1.10)

BMI

0.05

1.13 (1.00–1.29)

1.12 (0.96–1.30)

0.001

1.14 (1.04–1.25)

1.13 (1.01–1.26)

Previous vaginal deliveries

0.26

1.28 (0.83–1.98)

1.57 (0.90–2.76)

0.45

1.15 (0.84–1.58)

1.18 (0.79–1.76)

Postmenopausal women

0.001

9.6 (2.09–4.35)

11.58 (1.78–75.1)

< 0.001

10.44 (2.41–45.2)

8.09 (0.98–67.05)

Previous vaginal operations

0.08

2.16 (0.99–4.74)

2.16 (0.86–5.44)

0.19

1.54 (0.81–2.93)

1.29 (0.59–2.80)

Chronic systemic diseases

1.00

1.09 (0.49–1.41)

0.95 (0.37–2.41)

0.045

2.23 (1.05–4.71)

1.84 (0.77–4.41)

Diabetes mellitus

1.00

1.00 (0.38–2.60)

0.77 (0.16–4.46)

0.07

2.46 (0.94–6.11)

0.86 (0.19–3.88)

Autoimmune diseases

1.00

1.36 (0.29–6.33)

3.23 (0.41–25.67)

0.48

1.64 (0.43–0.34)

1.99 (0.34–11.59)

Airway disorders

0.72

1.72 (0.40–2.58)

0.90 (0.15–5.54)

0.51

1.73 (0.51–5.89)

0.4 (0.08–2.14)

POP–Q III vs II

0.02

4.71 (1.26–17.5)

6.32 (1.07–37.52)

< 0.001

1.24 (1.10–4.40)

1.36 (1.08–4.10)

Urge symptoms

0.09

4.44 (0.90–21.74)

4.85 (0.91–25.94)

0.10

2.48 (0.85–7.18)

3.02 (0.84–10.90)

Duration of operation

0.41

0.98 (0.93–1.03)

0.97 (0.91–1.03)

0.22

1.05 (1.01–1.09)

1.03 (0.98–1.09)

Estimated average blood loss

< 0.001

0.96 (0.95–0.98)

0.96 (0.94–0.98)

< 0.001

0.96 (0.94–0.97)

0.96 (0.94–0.98)

Intraoperative bladder injury^b

1.00

1.02 (0.98–1.05)

n.m.^b

0.33

1.02 (0.99–1.05)

n.m.^b

Blood transfusion

n.m^b

n.m^b

n.m.^b

1.00

0.99 (0.98–1.01)

n.m.^b

Reoperation^b

0.15

0.36 (0.11–1.21)

0.22 (0.04–1.10)

< 0.001

0.15 (005–0.43)

0.07 (0.02–0.32)

POP

0.44

0.38 (0.07–2.04)

0.26 (0.04–1.96)

< 0.001

0.10 (0.02–0.43)

0.05 (0.006–0.41)

SUI

1.00

1.00 (0.06–16.39)

0.19 (0.01–5.7)

0.06

0.17 (0.02–1.34)

0.11 (0.06–0.89)

Vaginal wall extrusion

0.11

0.15 (0.02–1.31)

0.13 (0.009–1.71)

n.m

n.m.^b

n.m.^b

Bleeding

0.24

0.95 (0.90–1.01)

n.m.^b

1.00

0.99 (0.98–1.01)

0.89 (0.68–1.12)

Postoperative pain

1.00

1.02 (0.98–1.05)

n.m.^b

0.33

1.02 (0.99–1.05)

n.m.^b

Total retention

1.00

0.98 (0.95–1.02)

n.m.^b

1.00

0.99 (0.98–1.01)

n.m.^b

Successful treatment of POP–Q

0.27

3.22 (0.62–16.67)

2.94 (0.47–18.6)

< 0001

16.5 (3.85–70.77)

14.16 (3.09–65.00)

Successful treatment of SUI

0.004

9.58 (2.09–43.9)

72.2 (8.56–606.65)

< 0.001

18.95 (4.43–81.13)

96.2 (7.40–1250.0)

Urinary tract infection

0.66

0.74 (0.31–1.79)

0.70 (0.26–1.87)

1.00

1.95 (0.43–2.19)

0.92 (0.34–2.45)

De novo urge symptoms

1.00

0.86 (0.29–2.53)

0.89 (0.25–3.22)

< 0.001

1.13 (1.03–1.23)

1.10 (1.06–1.19)

Average time to extrusion observed

0.99

n.m.^b

n.m.^b

n.m.^b

n.m.^b

n.m.^b